If you have conditions that qualify you to take these medications, you may be interested for the same reason that anyone is: Youre curious if they could help improve your health
This work was led by Frederick Banting, a Canadian surgeon with the support of John McLeod, a physiologist and expert in diabetes
Common GLP-1 side effects include nausea, vomiting, diarrhea, constipation, and injection-site reactions
No clinical trial has answered this question definitively yet, but the mechanistic rationale is compelling
The Chinese government's 14th Five-Year Plan for healthcare specifically identifies diabetes management as a chronic disease prevention priority, with investment in guideline-based pharmacotherapy programs that are driving adoption of evidence-based GLP-1 therapy in public healthcare settings Middle East & Africa and Latin America GLP-1 Receptor Agonist Market Insights The Middle East represents a commercially interesting GLP-1 market because the Gulf states combine high rates of type 2 diabetes and obesity the UAE's adult obesity rate exceeds 37%, among the world's highest with high-income consumer populations and expanding private health insurance coverage
And which one matters most depends on the cancer